New Enterprise Associates 14, L.P. Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for New Enterprise Associates 14, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of New Enterprise Associates 14, L.P.. New Enterprise Associates 14, L.P. is 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Galera Therapeutics, Inc. ($GRTX) and 10% Owner in Loxo Oncology, Inc. ($LOXO) and 10% Owner in Casper Sleep Inc. ($CSPR) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in IMARA Inc. ($IMRA) and 10% Owner in Oyster Point Pharma, Inc. ($OYST) and 10% Owner in Surface Oncology, Inc. ($SURF).
Latest Insider Trading Transactions of New Enterprise Associates 14, L.P.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADAP, APPN, CSPR, CERC, GRTX, IMRA, LOXO, MRSN, MULE, OYST, SURF, SYBX, TCON
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 16 2020 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Sell | J | 0.00 | 2,000,000 | 0 | 5,959,520 | 8 M to 6 M (-25.13 %) |
| May 22 2020 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 3.66 | 420,000 | 1,535,562 | 2,892,877 | 3.3 M to 2.9 M (-12.68 %) |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Sell | J | 0.00 | 4,000,000 | 0 | 7,959,520 | 12 M to 8 M (-33.45 %) |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | X | 0.05 | 70,593 | 3,530 | 0 | |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 2.91 | 1,211 | 3,524 | 11,959,520 | 12 M to 12 M (-0.01 %) |
| Apr 13 2020 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | X | 0.05 | 70,593 | 3,530 | 11,960,731 | 11.9 M to 12 M (+0.59 %) |
| Mar 16 2020 | IMRA | IMARA Inc. | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 5,625,926 | 0 | 0 | |
| Mar 16 2020 | IMRA | IMARA Inc. | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 15,323,454 | 0 | 0 | |
| Mar 16 2020 | IMRA | IMARA Inc. | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,342,780 | 0 | 0 | |
| Mar 16 2020 | IMRA | IMARA Inc. | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 16.00 | 475,000 | 7,600,000 | 4,013,995 | 3.5 M to 4 M (+13.42 %) |
| Mar 16 2020 | IMRA | IMARA Inc. | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,538,995 | 0 | 3,538,995 | 0 to 3.5 M |
| Feb 12 2020 | CSPR | Casper Sleep Inc. | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 12.00 | 1,250,000 | 15,000,000 | 6,222,412 | 5 M to 6.2 M (+25.14 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,354,829 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 9,600,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 8,975,000 | 0 | 0 | |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 12.00 | 416,666 | 4,999,992 | 4,358,047 | 3.9 M to 4.4 M (+10.57 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 267,935 | 0 | 3,941,381 | 3.7 M to 3.9 M (+7.29 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,898,524 | 0 | 3,673,446 | 1.8 M to 3.7 M (+106.96 %) |
| Nov 12 2019 | GRTX | Galera Therapeutic ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,774,922 | 0 | 1,774,922 | 0 to 1.8 M |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,061,547 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 3,606,282 | 0 | 0 | |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 16.00 | 935,000 | 14,960,000 | 5,925,287 | 5 M to 5.9 M (+18.74 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,061,547 | 0 | 4,990,287 | 3.9 M to 5 M (+27.02 %) |
| Nov 04 2019 | OYST | Oyster Point Pharm ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,606,282 | 0 | 3,928,740 | 322.5 K to 3.9 M (+1,118.37 %) |
| Mar 06 2019 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 4.00 | 3,750,000 | 15,000,000 | 11,890,138 | 8.1 M to 11.9 M (+46.07 %) |
| Sep 10 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.67 | 3,000,000 | 5,000,100 | 82,978,668 | 80 M to 83 M (+3.75 %) |
| May 09 2018 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 12,679,970 | 0 | 0 | |
| May 09 2018 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Sell | U | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
| May 09 2018 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 12,679,970 | 0 | 12,679,970 | 0 to 12.7 M |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,995,000 | 0 | 0 | |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 133,333 | 1,999,995 | 3,312,877 | 3.2 M to 3.3 M (+4.19 %) |
| Apr 23 2018 | SURF | Surface Oncology, ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 3,179,544 | 0 | 3,179,544 | 0 to 3.2 M |
| Mar 28 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.92 | 6,000,000 | 11,500,200 | 79,978,672 | 74 M to 80 M (+8.11 %) |
| Mar 28 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.90 | 571,164 | 1,087,553 | 73,978,672 | 73.4 M to 74 M (+0.78 %) |
| Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | P | 2.70 | 707,964 | 1,911,503 | 707,964 | |
| Mar 27 2018 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 2.70 | 707,964 | 1,911,503 | 3,466,003 | 2.8 M to 3.5 M (+25.67 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.95 | 294,090 | 572,358 | 73,407,508 | 73.1 M to 73.4 M (+0.40 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.90 | 869,574 | 1,655,669 | 73,113,418 | 72.2 M to 73.1 M (+1.20 %) |
| Mar 23 2018 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 1.81 | 104,844 | 189,820 | 72,243,844 | 72.1 M to 72.2 M (+0.15 %) |
| Feb 15 2018 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 2,724,202 | 0 | 0 | |
| Feb 15 2018 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Sell | J | 0.00 | 2,724,202 | 0 | 0 | 2.7 M to 0 (-100.00 %) |
| Feb 15 2018 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 2,724,202 | 0 | 2,724,202 | 0 to 2.7 M |
| Jan 26 2018 | MIRN | SYNLOGIC, INC. | New Enterprise Associates 14, ... | 10% Owner | Grant | A | 9.75 | 410,000 | 3,997,500 | 4,228,940 | 3.8 M to 4.2 M (+10.74 %) |
| Nov 27 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 569,620 | 0 | 2,724,202 | |
| Nov 27 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 19.49 | 569,620 | 11,101,894 | 0 | 569.6 K to 0 (-100.00 %) |
| Nov 27 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 569,620 | 0 | 569,620 | 0 to 569.6 K |
| Nov 21 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 2,820,516 | 0 | 3,293,822 | |
| Nov 21 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Sell | S | 19.49 | 2,820,516 | 54,971,857 | 0 | 2.8 M to 0 (-100.00 %) |
| Nov 21 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 2,820,516 | 0 | 2,820,516 | 0 to 2.8 M |
| Aug 30 2017 | MIRN | SYNLOGIC, INC. | New Enterprise Associates 14, ... | 10% Owner | Grant | A | 0.00 | 3,394,439 | 0 | 3,818,940 | 424.5 K to 3.8 M (+799.63 %) |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 2,216,626 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 18,001,419 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 11,931,173 | 0 | 0 | |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 15.00 | 1,000,000 | 15,000,000 | 8,140,138 | 7.1 M to 8.1 M (+14.01 %) |
| Jul 06 2017 | MRSN | Mersana Therapeuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 7,140,138 | 0 | 7,140,138 | 0 to 7.1 M |
| May 31 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 6,114,338 | |
| May 31 2017 | APPN | APPIAN CORP | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 6,114,338 | 0 | 0 | |
| Mar 28 2017 | ADAP | Adaptimmune Therap ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 0.70 | 12,870,000 | 9,009,000 | 72,139,000 | 59.3 M to 72.1 M (+21.71 %) |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | J | 0.00 | 12,679,970 | 0 | 12,679,970 | |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 605,668 | 0 | 0 | |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 2,064,048 | 0 | 0 | |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 8,000,038 | 0 | 0 | |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,689,436 | 0 | 0 | |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Sell | J | 0.00 | 12,679,970 | 0 | 0 | 12.7 M to 0 (-100.00 %) |
| Mar 22 2017 | MULE | MULESOFT, INC | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 12,359,190 | 0 | 12,679,970 | 320.8 K to 12.7 M (+3,852.86 %) |
| Nov 29 2016 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 5.75 | 869,565 | 4,999,999 | 2,758,039 | 1.9 M to 2.8 M (+46.05 %) |
| Oct 20 2015 | CERC | Cerecor Inc. | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 16,638,880 | 0 | 0 | |
| Oct 20 2015 | CERC | Cerecor Inc. | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 594,245 | 0 | 594,245 | 0 to 594.2 K |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 583,559 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,241,650 | 0 | 0 | |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 7.00 | 857,142 | 5,999,994 | 2,971,517 | 2.1 M to 3 M (+40.54 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Buy | J | 0.00 | 31,650 | 0 | 2,114,375 | 2.1 M to 2.1 M (+1.52 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 583,559 | 0 | 2,082,725 | 1.5 M to 2.1 M (+38.93 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Buy | J | 0.00 | 257,516 | 0 | 1,499,166 | 1.2 M to 1.5 M (+20.74 %) |
| Oct 06 2015 | MIRN | Mirna Therapeutics ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,241,650 | 0 | 1,241,650 | 0 to 1.2 M |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 5,373,396 | 0 | 0 | |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 10.00 | 500,000 | 5,000,000 | 1,888,474 | 1.4 M to 1.9 M (+36.01 %) |
| Feb 05 2015 | TCON | Tracon Pharmaceuti ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,388,474 | 0 | 1,388,474 | 0 to 1.4 M |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | New Enterprise Associates 14, ... | 10% Owner | Option Exercise | C | 0.00 | 1,558,651 | 0 | 0 | |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | New Enterprise Associates 14, ... | 10% Owner | Buy | P | 13.00 | 230,769 | 2,999,997 | 1,789,420 | 1.6 M to 1.8 M (+14.81 %) |
| Aug 06 2014 | LOXO | Loxo Oncology, Inc ... | New Enterprise Associates 14, ... | 10% Owner | Buy | C | 0.00 | 1,558,651 | 0 | 1,558,651 | 0 to 1.6 M |
Page: 1